|
Volumn 31, Issue SUPPL.1, 2010, Pages
|
Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan
b
Almirall SpA
(Italy)
|
Author keywords
Acute treatment; Almotriptan; Menstrual migraine; Migraine associated symptoms
|
Indexed keywords
ALMOTRIPTAN;
PLACEBO;
SEROTONIN AGONIST;
TRYPTAMINE DERIVATIVE;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG TOLERABILITY;
FOLLOW UP;
HUMAN;
MENSTRUAL MIGRAINE;
NAUSEA;
OSMOPHOBIA;
PHOBIA;
PHONOPHOBIA;
PHOTOPHOBIA;
UNSPECIFIED SIDE EFFECT;
VOMITING;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DISEASE COURSE;
DOUBLE BLIND PROCEDURE;
FEMALE;
MIGRAINE WITHOUT AURA;
MULTICENTER STUDY;
PAIN ASSESSMENT;
PREMENSTRUAL SYNDROME;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADULT;
CROSS-OVER STUDIES;
DISEASE PROGRESSION;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MIGRAINE WITHOUT AURA;
NAUSEA;
PAIN MEASUREMENT;
PHOTOPHOBIA;
PREMENSTRUAL SYNDROME;
SEROTONIN AGONISTS;
TREATMENT OUTCOME;
TRYPTAMINES;
VOMITING;
|
EID: 77955886102
PISSN: 15901874
EISSN: 15903478
Source Type: Journal
DOI: 10.1007/s10072-010-0302-9 Document Type: Conference Paper |
Times cited : (12)
|
References (5)
|